| 查看: 469 | 回复: 0 | |||
[交流]
3-13岁变应性鼻炎患儿舌下特异性免疫治疗的疗效和安全性评估
|
|
Background: Sublingual immunotherapy (SLIT) is recommended for allergic diseases. However, clinical studies containing evidence-based data of thistreatment in young children, which is rarely reported in the literature, are needed. This study was designed to assess the efficacy and safety of SLIT in children,including very young children. Methods: Two hundred sixty-four children aged 3–13 years old (133 children, 3–5 years old) with Dermatophagoides farinae–induced allergic rhinitiswith or without asthma treated by standard harmacotherapy had randomly received either SLIT (SLIT group) or no SLIT (control group) for 12 months. Symptoms, medications, visual analog scale (VAS) and presence of adverse events (AEs) were assessed at monthly visits. Skin-prick test and Dermatophagoides farinae-specific IgE and IgG4 were easured before and after treatment. Results: Both treatments were effective in the global clinical scores during the first seven visits when compared with baseline (all, p 0.01), and SLIT showed lower symptoms scores and VAS scores throughout this period (all, p 0.01). These improvements continued until the later visits only in the SLIT group. Also, the asthma medication consumption was decreased by SLIT treatment only at the end of study (p 0.01). The specific IgG4 was significantly increased after SLIT treatment when compared with the control group, but no significant change of specific IgE was observed in either groups. In the SLIT group, there was no significant difference between children less than or more than 5 years old in terms of clinical efficacy, onset of action, immunologic parameters, and safety. No severe systemic AEs were reported. Conclusion: SLIT is effective and well-tolerated in children with allergic rhinitis 3-13 years old. |
» 猜你喜欢
细胞 ROS 荧光检测:探针选型、孵育条件与结果质控要点
已经有0人回复
肿瘤为什么偏爱糖酵解?一文说清机制、意义与验证思路
已经有0人回复
预防医学论文润色/翻译怎么收费?
已经有113人回复
细胞 RNA 提取:12 孔板体系样本处理与质控要点汇总
已经有0人回复
实验答疑室丨IHC还是IF?选错显色方式,样本可能白做
已经有0人回复
【模型攻略】椎间盘“叛乱”如何平息?MDL破局造模周期与评估壁垒
已经有0人回复
外周血 PBMC 分离 CD8⁺T 细胞实操方案|纯度 & 活性把控要点
已经有0人回复
3D 肿瘤球长不均、容易散?这套方案帮你稳定成球
已经有0人回复
别让好本子倒在起跑线上:国自然评审最反感的14种写法
已经有0人回复
做 WB 栽在组织提蛋白上?这份实操经验收好
已经有0人回复










回复此楼